CASI Pharmaceuticals, Inc. (CASI) Financials

CASI Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 24.5 million 53.1 million
June 30, 2025 31.2 million 51.5 million
March 31, 2025 40.8 million 48.9 million
Dec. 31, 2024 53.7 million 51.8 million

CASI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 ? ?
June 30, 2025 ? ?
March 31, 2025 ? ?
Dec. 31, 2024 ? 1.3 million

CASI Net Income

No data available :(

CASI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 4.7 million - -
June 30, 2025 6.8 million - -
March 31, 2025 12.7 million - -
Dec. 31, 2024 16.1 million - 3.8 million

CASI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2025 16.0 million
June 30, 2025 15.5 million
March 31, 2025 15.5 million
Dec. 31, 2024 15.5 million

CASI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 - 1.4 million 9.5 million 4.6 million
June 30, 2025 - 1.7 million 11.0 million 5.0 million
March 31, 2025 - 1.9 million 11.9 million 4.2 million
Dec. 31, 2024 - 3.7 million 11.9 million 4.8 million

CASI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 3.1 million 2.4 million
June 30, 2025 4.2 million 2.1 million
March 31, 2025 6.2 million 2.6 million
Dec. 31, 2024 13.4 million 10.1 million

CASI Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CASI

Price: $0.21

52 week price:
0.14
3.09

Payout Ratio Range:
-7.98%
-5.06%

Earnings Per Share: -3.02 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: China

Volume: 21900

Ebitda: -1.6 million

Market Capitalization: 3.2 million

Links: